50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to detect cancer early, when it can be cured.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1289% match
“Our mission is to detect cancer and disease at earlier, more treatable stages by making screening easy and accessible.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-08-1876% match
“Our mission is to power precision proteomics to enable the earliest detection of disease.”In use 2026 – now·1 sighting·SEC Form 424B4, filed 2026-04-1771% match
“Our mission is to eliminate cancer and improve life.”In use 2021 – now·1 sighting·SEC Form 20-F, filed 2021-03-2470% match
“Our mission is to target cancer and transform lives through the development of innovative cancer treatments.”In use 2005 – now·1 sighting·SEC Form 10-K, filed 2005-03-1669% match
“Our mission is to transform deadly cancer into a chronic and eventually curable disease.”In use 2025 – now·1 sighting·SEC Form 20-F/A, filed 2025-05-1269% match
“Our mission is to enhance disease diagnosis by applying cutting-edge genetic diagnostic technologies, enabling earlier and more accurate detection for timely and improved treatment.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-3168% match
“Our mission is to combine the ingenuity of people with the power of data and technology to achieve new victories against cancer.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-11-2568% match
“Our mission is to advance and grow a portfolio of innovative, early-stage oncology assets based on the latest scientific breakthroughs focused on overcoming immune resistance and expanding the addressable patient population.”In use 2023 – now·1 sighting·SEC Form 20-F, filed 2023-07-3167% match
“Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-2767% match
“Our mission is to inspire hope for those battling cancer by expanding on the promise of targeted therapies.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-1567% match
“Our mission is to transform the active management of cancer through personalized testing.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-02-2367% match
“The Company’s mission is to revolutionize early detection of a wide array of animal related abnormalities.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-01-1367% match
“Our mission is to boldly innovate to create trusted solutions that detect, predict, and prevent disease.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-1967% match
“Our mission is to afford early non-invasive detection of possible physical abnormalities including breast growths, testicular growths, blood flow and more.”In use 2026 – now·1 sighting·SEC Form 20-F/A, filed 2026-05-0666% match
“Our mission is to create therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-04-1666% match
“Our mission is to help improve the lives of those affected by cancer through translating cancer discoveries into better patient care.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-03-1666% match
“Our mission is to heal and empower cancer patients through compassion, innovation, and state-of-the-art medical care.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-2866% match
“Our mission is to transform cancer treatment and prevention globally by driving technological innovation and accelerating the adoption of precision oncology medicine.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-06-2266% match
“Our mission is to accelerate scientific and medical breakthroughs and deliver well-tolerated medicines with greater efficacy and safety to people with the deadliest cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0566% match
“Our mission is to cure genetic disease, overcome cancer, and feed the planet.”In use 2019 – now·1 sighting·SEC Form S-1/A, filed 2019-03-1366% match
“Our mission is to discover and develop a pipeline of EPBs to treat a broad range of diseases and disorders, with an initial focus on cancers with a high unmet medical need.”In use 2022 – now·1 sighting·SEC Form 20-F, filed 2022-04-2666% match
“Our mission is to harness the power of the immune system to improve lives and eradicate cancer.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1265% match
“Our mission is to improve the lives of patients by developing novel therapeutics to treat some of the most devastating types of cancer.”In use 2026 – now·1 sighting·SEC Form 10-K/A, filed 2026-06-0265% match
“Our mission is to erase cancer by eradicating RAS/MAPK pathway-driven cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1265% match
“Our mission is to discover and develop novel therapeutics to address significant medical needs.”In use 2007 – now·1 sighting·SEC Form 10-K, filed 2007-03-1965% match
“Our mission is to address the significant need for new treatments in cancers of the bone in children and young adults.”In use 2025 – now·1 sighting·SEC Form S-1, filed 2025-08-0465% match
“Our mission is to become a leader in bringing innovative cancer treatments to the market and to improve patient health outcomes.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2065% match
“Our mission is to improve the treatment and detection of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-12-0365% match
“Our mission is to develop treatments for serious diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2265% match
“Our mission is to make a meaningful impact on the lives of patients with cancer and high unmet medical needs by delivering novel, PRAME-directed immunotherapies that provide tangible clinical benefits.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-03-0565% match
“Our mission is to develop next-generation, potentially curative cell therapies for people with cancer.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1265% match
“Our mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers.”In use 2019 – now·1 sighting·SEC Form 10-K, filed 2019-03-0664% match
“Our mission is to develop novel treatments for dormant cancers: targeting cancer resistance, metastasis, and relapse.”In use 2022 – now·1 sighting·SEC Form S-1/A, filed 2022-12-0864% match
“Our mission is to improve the quality of life of people suffering from cancer and to increase shareholder value by commercializing our platform technologies through in-house development, joint ventures, strategic alliances and licensing arrangements.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-07-2964% match
“Our mission is to improve the lives of cancer patients by developing next-generation cancer therapies that are designed to maximize efficacy while minimizing the toxicity and side effects traditionally associated with cancer treatment.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-02-2164% match
“Our mission is to profitably accelerate drug discovery.”In use 2005 – now·1 sighting·SEC Form 10-K/A, filed 2005-04-2964% match
“Our mission is to be the leading player in the development and commercialization of p53-targeted cancer therapies.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-1564% match
“Our mission is to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte, or TIL, cell therapies for patients with solid tumor cancers.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2464% match
“Our mission is to accelerate the discovery, development and global access to targeted radioligand therapies.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2764% match
“Our mission is to leverage an integrated and extensive genomics and transcriptomics discovery engine to identify antibodies targeted to newly discovered neoepitopes and to mobilize the human immune system of cancer patients to kill tumor cells and facilitate long-term remission.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-03-1564% match
“Our mission is to develop a portfolio of innovative product candidates for the treatment of cancer.”In use 2022 – now·1 sighting·SEC Form 424B4, filed 2022-02-0764% match
“Our mission is to harness the evolutionary power of the human immune system to provide patients fighting cancer with safe, effective therapies.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1864% match
“Our mission is to improve overall patient condition through innovative bio-immunotherapy with proven treatment protocols, to lower deaths associated with cancer and to reduce the cost of cancer treatment.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-2564% match
“Our mission is to improve lives through the curative potential of gene therapy.”In use 2021 – now·1 sighting·SEC Form 10-K, filed 2021-03-0164% match
“Our mission is to accelerate transformative therapies to improve the lives of people living with cancer and other serious diseases.”In use 2017 – now·1 sighting·SEC Form 10-K, filed 2017-02-2364% match
“Our mission is to develop new and effective immune-oncologic therapeutics.”In use 2015 – now·1 sighting·SEC Form 10-K, filed 2015-10-1464% match
“Our mission is to transform cancer care.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-03-0764% match
“Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest unmet medical need – aggressive cancers where current therapies are inadequate.”In use 2016 – now·1 sighting·SEC Form 10-K, filed 2016-02-2964% match
“Our mission is to make a difference in time for underserved lung cancer patients.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-04-1764% match
Showing 1–50 of 50